University of Versailles: Clinical Trials

19 trials sponsored by University of Versailles, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 6 terminated, 1 unknown. 10 Phase 3, 6 Phase 2, 5 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 310Completed 6, Terminated 4
Phase 26Completed 5, Terminated 1
Not applicable5Completed 2, Terminated 2, Unknown 1
Phase 11Completed 1

Follow University of Versailles: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neuropathology in Adults Intensive Care Unit Patients With COVID 19
autopsy - COVID 19
CompletedUniversity of Versailles72020-03-102020-07-01
The Trauma INtramuscular Tranexamic Acid Clinical Trial
Tranexamic 1 gram - Traumatic Haemorrhage
Phase 1 / Phase 2CompletedLondon School of Hygiene and Tropical Medicine312019-09-172020-04-10
Stimulation Galvanique Vestibulaire
galvanic vestibular stimulation - Hypertensive Hemorrhage of Right Parietal Lobe
Not applicableTerminatedCentre d'Investigation Clinique et Technologique 805162014-04-012015-02-03
Robust Intelligent Keyboard for Quadraplegic Patients
Scanning device, RoBIK Brain-Computer Interface - Quadraplegia
Not applicableUnknownCentre d'Investigation Clinique et Technologique 805202013-02-012018-02-01
Effect of Mechanical Insufflation-exsufflation on Respiratory Parameters in Two Neuromuscular Populations.
Plethysmography opto electronic, respiratory parameters - Mechanical Insufflation-exsufflation Session ( With Cough Assist)
Not applicableCompletedCentre d'Investigation Clinique et Technologique 805162010-11-012015-03-24
Impact of Patient Controlled Positive End-expiratory Pressure on Speech in Tracheostomized Ventilated Patients
Eole 3 ventilator - Resmed - Chronic Respiratory Failure
Not applicableCompletedUniversity of Versailles142010-06-012011-11-28
Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu
hydrocortisone, isotonic saline - Pneumonia, Viral, Influenza in Humans
Phase 3TerminatedUniversity of Versailles402010-03-012014-12-18
Brain Computer Interface for Communication in ICU: a Feasibility Study
Tetraplegia, Guillain-Barre Syndrome
CompletedUniversity of Versailles122010-01-012012-05-23
Speech Effects of a Speaking Valve Versus External Positive End-expiratory Pressure (PEEP) in Tracheostomized Ventilator-Dependent Neuromuscular Patients
Passy Muir Valve, Positive end expiratory pressure - Tracheostomy, Mechanical Ventilation
Phase 2 / Phase 3CompletedUniversity of Versailles102008-12-012009-09-17
Activated Protein C and Corticosteroids for Human Septic Shock
placebos, hydrocortisone and fludrocortisone and placebo, recombinant human activated protein C and placebos - Septic Shock
Phase 3CompletedUniversity of Versailles12412008-03-012017-06-14
Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock
recombinant human insulin, hydrocortisone, fludrocortisone - Septic Shock
Phase 3CompletedUniversity of Versailles5082006-01-012010-04-06
Near Infrared Spectroscopy (NIRS) in Severe Sepsis
Near Infrared Spectroscopy, conventional - Critical Illness, Severe Sepsis
Phase 2 / Phase 3TerminatedUniversity of Versailles1032005-07-012016-07-20
Early Mechanical Ventilation for Guillain Barré Syndrome
mechanical ventilation, physiotherapy and oxygen if needed - Guillain Barré Syndrome, Acute Respiratory Failure
Phase 2CompletedUniversity of Versailles502005-04-012016-07-20
Efficacy and Safety of DHEA for Myotonic Dystrophy
dehydroepiandrosterone 100 and 400 mg - Myotonic Dystrophy
Phase 2 / Phase 3CompletedUniversity of Versailles752004-11-012010-04-06
Efficacy and Safety of Colloids Versus Crystalloids for Fluid Resuscitation in Critically Ill Patients
Crystalloids, Colloids - Critical Illness
Phase 3CompletedUniversity of Versailles28572003-02-012014-07-01
Intermittent Positive-Pressure Breathing Effects in Patients With High Spinal Cord Injury
intermittent positive-pressure breathing (IPPB) - Central Cord Injury Syndrome, Central Spinal Cord Syndrome
Not applicableTerminatedUniversity of Versailles142002-12-012007-05-22
Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic Shock
norepinephrine and dobutamine, epinephrine plus placebo of dobutamine - Septic Shock, Severe Sepsis
Phase 2 / Phase 3CompletedUniversity of Versailles3301999-10-012010-07-22
Hyperbaric Oxygen Therapy for Comatose Patients With Acute Carbon Monoxide Poisoning
Hyperbaric oxygen therapy, hyperbaric oxygen therapy - Carbon Monoxide Poisoning
Phase 3TerminatedUniversity of Versailles1701989-10-012010-04-08
Hyperbaric Oxygen Therapy for Acute Domestic Carbon Monoxide (CO) Poisoning
normobaric oxygen therapy, Hyperbaric oxygen therapy - Carbon Monoxide Poisoning
Phase 3TerminatedUniversity of Versailles1791989-10-012010-04-09

Conditions studied

Quadriplegia (3)  ·  Sepsis (3)  ·  Shock, Septic (3)  ·  Carbon Monoxide Poisoning (2)  ·  Critical Illness (2)  ·  Guillain-Barre Syndrome (2)  ·  Inflammation (2)  ·  Neuromuscular Diseases (2)  ·  Acute Lung Injury (1)  ·  Adrenal Insufficiency (1)  ·  COVID-19 (1)  ·  Central Cord Syndrome (1)  ·  Coma (1)  ·  Communication (1)  ·  Coronavirus Infections (1)

Interventions

Hydrocortisone (3)  ·  Fludrocortisone (2)  ·  Hyperbaric Oxygenation (2)  ·  Autopsy (1)  ·  Colloids (1)  ·  Crystalloid Solutions (1)  ·  Dobutamine (1)  ·  Epinephrine (1)  ·  Intermittent Positive-Pressure Breathing (1)  ·  Norepinephrine (1)  ·  Physical Therapy Modalities (1)  ·  Positive-Pressure Respiration (1)  ·  Respiration, Artificial (1)  ·  Saline Solution (1)  ·  Sodium Chloride (1)

Countries

France (18)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Canada (1)  ·  Germany (1)  ·  Greece (1)  ·  Spain (1)  ·  Tunisia (1)

Top investigators

Djillali Annane, MD, PhD (4)  ·  Christian Brun Buisson, MD (2)  ·  Djillali Annane, MD (2)  ·  Alain Cariou, MD (1)  ·  Benoit Misset, MD (1)  ·  Charles Mayaud (1)  ·  Christian Perronne (1)  ·  Claude Martin, MD (1)  ·  Djillali Annane, MD,PhD (1)  ·  Eric Bellissant, MD, PhD (1)

Results publications

PMID 17720019, PMID 18602082, PMID 18678823, PMID 20103758, PMID 22120766, PMID 23525934, PMID 23715608, PMID 24108515, PMID 28988172, PMID 29490185, PMID 29555789, PMID 32997260, PMID 33010927, PMID 38310918

NIH funding

2019 (1)